These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 33483461)
21. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma. Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927 [TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
24. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data. Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975 [TBL] [Abstract][Full Text] [Related]
25. MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression. Shi W; Wang X; Ruan L; Fu J; Liu F; Qu J Pharmazie; 2017 Nov; 72(11):694-699. PubMed ID: 29442045 [TBL] [Abstract][Full Text] [Related]
26. Differentially Expressed Gene Screening, Biological Function Enrichment, and Correlation with Prognosis in Non-Small Cell Lung Cancer. Huang H; Huang Q; Tang T; Zhou X; Gu L; Lu X; Liu F Med Sci Monit; 2019 Jun; 25():4333-4341. PubMed ID: 31181055 [TBL] [Abstract][Full Text] [Related]
27. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis. Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105 [TBL] [Abstract][Full Text] [Related]
28. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis. Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638 [TBL] [Abstract][Full Text] [Related]
29. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis. Wu M; Sun Y; Wu J; Liu G Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586 [TBL] [Abstract][Full Text] [Related]
30. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network. Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
32. Upregulation of KIF26B, Cell Migration and Proliferation of Human Ovarian Cancer Cell Lines In Vitro, and Patient Outcomes from Human Bioinformatic Analysis. Yang X; Zhang L; Xie L Med Sci Monit; 2018 Jun; 24():3863-3872. PubMed ID: 29880787 [TBL] [Abstract][Full Text] [Related]
33. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis. Li D; Yin Y; He M; Wang J Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701 [TBL] [Abstract][Full Text] [Related]
34. Identification of metastasis and prognosis-associated genes for serous ovarian cancer. Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146 [TBL] [Abstract][Full Text] [Related]
35. A Prognostic Model Based on Six Metabolism-Related Genes in Colorectal Cancer. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Biomed Res Int; 2020; 2020():5974350. PubMed ID: 32953885 [TBL] [Abstract][Full Text] [Related]
36. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis. Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979 [TBL] [Abstract][Full Text] [Related]
37. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. Vorvis C; Hatziapostolou M; Mahurkar-Joshi S; Koutsioumpa M; Williams J; Donahue TR; Poultsides GA; Eibl G; Iliopoulos D Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1124-37. PubMed ID: 27151939 [TBL] [Abstract][Full Text] [Related]
38. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins. Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227 [TBL] [Abstract][Full Text] [Related]
39. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis. Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743 [TBL] [Abstract][Full Text] [Related]
40. Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients. Zhang X; Yin S; Ma K J Int Med Res; 2020 Jun; 48(6):300060520932112. PubMed ID: 32567431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]